Table 1 Patient and tumour characteristics
N (%) | |
|---|---|
No. of patients | 49 |
Age (years) | |
Median | 55 |
Range | [27–75] |
Median disease-free interval (months) | 34 |
Menopausal status | |
Pre | 33 (67) |
Post | 16 (33) |
Estrogen receptors | |
Positive | 27 (55) |
Negative | 14 (29) |
Unknown | 8 (16) |
Prior therapy | |
Radiotherapy | 32 (65) |
Adjuvant chemotherapy | 25 (51) |
Adjuvant hormonotherapy | 13 (27) |
Hormonotherapy for MBC | 17 (35) |
Karnofsky performance status | |
100% | 19 (39) |
90–80% | 24 (49) |
70% | 6 (12) |
Visceral involvement | 42 (86) |
No. of organs involved | |
1 | 10 (20) |
2 | 21 (43) |
⩾3 | 18 (37) |
